Loading...
XNYS
KVUE
Market cap36bUSD
Jul 10, Last price  
19.48USD
1D
-0.57%
1Q
10.55%
IPO
-27.62%
Name

Kenvue Inc

Chart & Performance

D1W1MN
XNYS:KVUE chart
P/E
25.44
P/S
2.47
EPS
0.77
Div Yield, %
4.30%
Shrs. gr., 5y
0.37%
Rev. gr., 5y
0.89%
Revenues
15.12b
-2.14%
14,324,000,00014,467,000,00015,054,000,00014,950,000,00015,444,000,00015,455,000,00015,124,000,000
Net income
1.47b
+42.72%
1,435,000,000-879,000,0002,078,000,0002,064,000,0001,664,000,0001,030,000,0001,470,000,000
CFO
2.20b
+24.19%
2,998,000,0003,397,000,000334,000,0002,525,000,0003,168,000,0001,769,000,0002,197,000,000
Dividend
Nov 12, 20250.2075 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
IPO date
May 04, 2023
Employees
22,000
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT